Drug Shortage Report for AA-AMILZIDE
Report ID | 157133 |
Drug Identification Number | 00784400 |
Brand name | AA-AMILZIDE |
Common or Proper name | AA-AMILZIDE |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | AMILORIDE HYDROCHLORIDE HYDROCHLOROTHIAZIDE |
Strength(s) | 5MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1000BTL |
ATC code | C03EA |
ATC description | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-03-25 |
Actual start date | |
Estimated end date | 2022-05-05 |
Actual end date | 2022-04-27 |
Shortage status | Resolved |
Updated date | 2022-04-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-04-29 | French | Compare |
v6 | 2022-04-29 | English | Compare |
v5 | 2022-04-14 | French | Compare |
v4 | 2022-04-14 | English | Compare |
v3 | 2022-03-26 | English | Compare |
v2 | 2022-03-23 | French | Compare |
v1 | 2022-03-23 | English | Compare |
Showing 1 to 7 of 7